| Titre : | American Journal on Addictions, Vol.13, Suppl.1 - May-June 2004 - Buprenorphine for office-based treatment of opiate dependence: U.S. and international field experience |
| Type de document : | Bulletin : Périodique |
| Paru le : | 15/05/2004 |
| Année de publication : | 2004 |
| Format : | S1-S78 |
| Langues: | Anglais |
| Cote : | Abonnement |
| Lien : | http://onlinelibrary.wiley.com/doi/10.1111/ajad.2004.13.issue-S1/issuetoc |
Dépouillements
Ajouter le résultat dans votre panierArticle : Périodique
FRANÇAIS :
Article d'introduction au supplément de la revue consacré aux recommandations de la conférence de consensus de mars 2003, aux Etats-Unis sur l'utilisation de la buprénorphine en médecine générale. Des experts répondent aux questions[...]
Article : Périodique
J. C. WEST ;
WILK J. ;
SVISKIS D. ;
TRIFFLEMAN E. ;
D. S. RAE ;
NARROW W. E. ;
F. F. DUFFY ;
D. A. REGIER ;
T. R. KOSTEN
|
The aims of this study are to assess psychiatrists' comfort using office-based opiate agonist treatment (OBOT) and to identify psychiatrist characteristics associated with OBOT comfort. A random sample of 2, 323 AMA Master- file of Physicians ps[...]
Article : Périodique
ENGLISH :
In most European countries, methadone treatment is provided to only 20-30% of opiate abusers who need treatment due to regulations and concerns about safety. To address this need in France, all registered rnedical doctors since 1995 [...]
Article : Périodique
N. LINTZERIS ;
A. RITTER ;
PANJARI M. ;
N. CLARK ;
KUTIN J. ;
G. BAMMER
|
Buprenorphine was registered in Australia as a maintenance and detoxification agent for the management of opioid dependence in November, 2000, and became widely available in August 2001. This paper provides an overview of key developments in the[...]
Article : Périodique
L. AMASS ;
W. LING ;
T. E. FREESE ;
C. REIBER ;
J. J. ANNON ;
A. J. COHEN ;
D. McCARTY ;
M. S. REID ;
L. S. Jr BROWN ;
C. CLARK ;
ZIEDONIS D. M. ;
J. KREJCI ;
STINE S. ;
T. WINHUSEN ;
G. BRIGHAM ;
D. BABCOCK ;
MUIR J. A. ;
B. J. BUCHAN ;
T. HORTON
|
In October 2002, the US Food and Drug Administration approved buprenorphine-naloxone (Suboxone) sublingual tablets as an opioid dependence treatment available for use outside traditionally licensed opioid treatment programs. The NIDA Center for [...]
Article : Périodique
Improving office-based treatment of opioid dependence requires an evaluation of processes of care. We evaluated the care provided by physicians to opioid dependent patients during a trial of office-based methadone maintenance. We conducted chart[...]
Exemplaires
| Disponibilité |
|---|
| aucun exemplaire |
Accueil
